Table 2.
Age-standardized mortality rate (per 100,000 persons) |
Average APC (95% CI) |
||||||
---|---|---|---|---|---|---|---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2018–2023 | |
Hepatocellular carcinoma | 7.95 | 7.72 | 7.60 | 7.59 | 7.38 | 7.42 | –1.4 (–2.0, –0.7)* |
Race and ethnicity | |||||||
Non-Hispanic White | 6.78 | 6.69 | 6.63 | 6.64 | 6.51 | 6.59 | –0.6 (–1.1, –0.1)* |
Non-Hispanic Black | 11.20 | 10.79 | 9.87 | 9.32 | 9.15 | 9.36 | –3.9 (–6.6, –1.0)* |
Non-Hispanic Asian | 9.68 | 9.29 | 9.27 | 9.25 | 8.52 | 8.34 | –2.8 (–4.3, –1.3)* |
Non-Hispanic American Indian or Alaska Native | 12.73 | 12.14 | 13.52 | 12.34 | 11.25 | 9.68 | –4.7 (–9.8, 0.7) |
Hispanic | 12.15 | 11.07 | 11.12 | 10.71 | 10.81 | 10.65 | –2.2 (–4.1, –0.3)* |
Sex | |||||||
Male | 12.63 | 12.27 | 11.95 | 11.71 | 11.46 | 11.51 | –1.9 (–2.7, –1.2)* |
Female | 3.89 | 3.78 | 3.86 | 3.87 | 3.83 | 3.89 | 0.1 (–0.7, 0.9) |
APC, annual percentage change; CI, confidence interval.
P<0.05.